biopharm.de valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Biopharm - Innovators In Regenerative Medicine: |
| Description | SYMBIOSIS offers a comprehensive range of analytical methods and services to meet your drug substance and drug product development |
| Keywords | SYMBIOSIS, analytical methods, GMP, GLP, Bioassay, N-terminale Sequenzierung, Stabilitätsprüfung, Proteinanalytik, Antikörperanalytik, Freigabeprüfung, MALDI TOF MS, Arzneibuchmethoden, NADA, Residual DNA, CE, Ph.Eur., N-terminal sequencing |
Server Information
| WebSite | |
| Host IP | 213.172.99.74 |
| Location | Germany |
Related Websites
| Site | Rank |
More to Explore
biopharm.de Valuation
|
US$1,597,892
Last updated: 2022-07-20 00:19:13
biopharm.de has Semrush global rank of 6,623,920. biopharm.de has an estimated worth of US$ 1,597,892, based on its estimated Ads revenue. biopharm.de receives approximately 184,373 unique visitors each day. Its web server is located in Germany, with IP address 213.172.99.74. According to SiteAdvisor, biopharm.de is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,597,892 |
| Daily Ads Revenue | US$1,475 |
| Monthly Ads Revenue | US$44,250 |
| Yearly Ads Revenue | US$530,992 |
| Daily Unique Visitors | 12,292 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| biopharm.de. | A | 300 | IP: 213.172.99.74 |
| biopharm.de. | NS | 300 | NS Record: ns2.mk.de. |
| biopharm.de. | NS | 300 | NS Record: ns1.mk.de. |
| biopharm.de. | MX | 300 | MX Record: 10 mx2.mk.de. |
| biopharm.de. | MX | 300 | MX Record: 10 mx3.mk.de. |
| biopharm.de. | MX | 300 | MX Record: 10 mx1.mk.de. |
| biopharm.de. | MX | 300 | MX Record: 10 mx4.mk.de. |
| biopharm.de. | TXT | 300 | TXT Record: v=spf1 a a:biofw.biopharm.de ip4:80.153.58.50 include:_spf.mk.de ~all |
HtmlToTextCheckTime:2022-07-20 00:19:13
| Events Downloads Home Company Mission History Management Contact Growth Factor Platform Wound healing Osteoporosis Maxillo-facial Degenerative disc disease Fracture Healing Parkinson disease Erectile dysfunction Osteoarthritis Licensing / Partnering IP Partner Publications Fracture Healing Growth factor mutant BB-1 mediated enhanced reconstruction of long bone architecture combining positive features of previously used growth factors. READ MORE Parkinson disease Thanks to its Growth-Factor platform, Biopharm has shown that rhGDF-5 protects nigrostriatal dopaminergic neurons in vivo. Advantage of intranasal delivery bypasses the blood-brain barrier READ MORE Maxillo-facial The product line MD05 has been developed as a novel regenerative bone substitute material related to dentistry for dental implantology and surgical treatment of periodontal disease. READ MORE Wound Healing Regenerative Wound Dressing: Efficient treatment of superficial skin lesions (e.g. diabetic ulcer, burns) in |
HTTP Headers
HTTP/1.1 307 Temporary Redirect Date: Wed, 03 Nov 2021 15:22:24 GMT Server: Apache X-Powered-By: PHP/7.3.29 Upgrade: h2,h2c Connection: Upgrade Location: http://biopharm.de/index.php?id=257 Content-Type: text/html; charset=UTF-8 HTTP/1.1 200 OK Date: Wed, 03 Nov 2021 15:22:24 GMT Server: Apache X-Powered-By: PHP/7.3.29 Content-Language: en Content-Length: 13761 Content-Type: text/html; charset=utf-8 |